Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Drug approved in combination with Merck's KGaA's Erbitux. French pharma group Pierre Fabre’s Braftovi has been recommended for NHS use by the UK’s National Institute for Health ... Braftovi (encorafenib) combined with has been recommended Merck

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer cancer for a decade – the EXTREME regimen of Eli Lilly’s Erbitux (cetuximab) with a platinum drug plus 5-FU – in the PD-L1-expressing group.

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial It also sells gastrointestinal cancer antibodies Erbitux (cetuximab) and recently launched Cyramza (ramucirumab), but was a late entrant into the cancer immunotherapy sector, and the Armo deal is viewed as a

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3 The biotech – based in Marseille, France – will proceed into a phase 3 trial evaluating monalizumab in combination with Eli Lilly’s Erbitux (cetuximab) in patients suffering from recurrent or metastatic squamous

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline It also sells gastrointestinal cancer antibodies Erbitux (cetuximab) and recently launched Cyramza (ramucirumab).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....